Ohio State Gynecologist Linked to Regular Payments From Epstein in Released Files

On February 10, 2026, newly released U.S. Department of Justice documents related to convicted sex offender Jeffrey Epstein revealed that Dr. Mark Landon, chair of the Department of Obstetrics and Gynecology at Ohio State University’s Wexner Medical Center, received regular payments from Epstein’s financial operation in the early 2000s. Records show quarterly payments of as much as $25,000 to Landon between 2001 and 2005, along with at least 10 packages sent to his Columbus home.

The Department of Justice files include emails and FedEx receipts referencing Landon by name and outlining proposed quarterly payments from Epstein’s firm, the New York Strategy Group, which was involved in managing financial arrangements for Epstein and associate Les Wexner. The records do not specify the contents of the packages or the precise nature of Landon’s consulting work.

Landon, a physician and longtime faculty member at Ohio State University since 1987, issued a public statement denying involvement in or knowledge of any criminal activities by Epstein or his associates. He said he was a paid consultant on biotech investment matters and had no clinical involvement with Epstein or his victims. “I find [Epstein’s conduct] reprehensible and I feel terrible for Epstein’s victims,” Landon said.

Ohio State University confirmed that it is reviewing the matter internally to understand the context of the payments and document citations, while noting the absence of evidence linking Landon to any criminal conduct. The university’s Wexner Medical Center spokesperson said the institution had no information contradicting Landon’s account and emphasized ongoing transparency efforts.

The disclosures have prompted public discussion about the extent and implications of connections between prominent institutions and Epstein’s network. While Landon has not been accused of wrongdoing, the case highlights the breadth of Epstein’s financial relationships and raises questions about institutional oversight of long-term consulting arrangements with controversial figures.